Cost analysis study of neuropsychiatric drugs: Role of National List of Essential Medicines, India.

Sarangi, Sudhir C; Kaur, Nivendeep; Tripathi, Manjari; Gupta, Yogendra K

Sarangi, Sudhir C; Kaur, Nivendeep; Tripathi, Manjari; Gupta, Yogendra K.

Sarangi SC; Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
Kaur N; Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
Tripathi M; Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Gupta YK; Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.

Neurol India ; 66(5): 1427-1433, 2018.

Article en En | MEDLINE | ID: mdl-30233018

Asunto(s)

Costos de los Medicamentos; Psicotrópicos/economía; Análisis Costo-Beneficio; Humanos; India

Palabras clave

Cost per defined daily dose; National List of Essential Medicines; cost variation; neuropsychiatric drugs

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psicotrópicos / Costos de los Medicamentos Tipo de estudio: Health_economic_evaluation Límite: Humans País como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google